Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 350 of 808 entries
View as:

Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00098865 Org: User:
Start: 09/30/02 End: 06/30/10 Due: 06/30/11

Pemetrexed in Patients With Advanced Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00424723 Org: User:
Start: 12/31/05 End: 03/31/10 Due: 03/31/11

Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02706249 Org: User:
Start: 04/30/16 End: 06/07/21 Due: 06/07/22

A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02448771 Org: User:
Start: 07/09/15 End: 03/03/21 Due: 03/03/22

Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL

Phase: N/A Priority: Normal
NCT ID: NCT01465334 Org: User:
Start: 12/31/11 End: 01/31/17 Due: 01/31/18

CONFIRM: Magnetic Resonance Guided Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04368702 Org: User:
Start: 05/01/21 End: 06/18/29 Due: 06/18/30

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00085397 Org: User:
Start: 03/31/04 End: - Due: -

Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT04899908 Org: User:
Start: 09/15/21 End: 02/28/26 Due: 02/28/27

Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00146614 Org: User:
Start: 07/31/02 End: 04/30/03 Due: 04/30/04

Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00146601 Org: User:
Start: 06/30/04 End: 07/31/07 Due: 07/31/08

Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC

Phase: N/A Priority: Normal
NCT ID: NCT05726370 Org: User:
Start: 05/20/23 End: 05/20/30 Due: 05/20/31

Geriatric Thoracic Surgery Ambulation Challenge

Phase: N/A Priority: Normal
NCT ID: NCT04630496 Org: User:
Start: 08/25/21 End: 01/01/26 Due: 01/01/27

A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT00136461 Org: User:
Start: 05/31/97 End: 08/31/00 Due: 08/31/01

RPFNA Assessment of Exercise Effect in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01961128 Org: User:
Start: 10/31/11 End: 03/31/14 Due: 03/31/15

Palbociclib With Everolimus + Exemestane In BC

Phase: N/A Priority: Normal
NCT ID: NCT02871791 Org: User:
Start: 08/24/16 End: 09/30/21 Due: 09/30/22

Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT00442130 Org: User:
Start: 02/28/07 End: 04/30/20 Due: 04/30/21

Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca

Phase: N/A Priority: Normal
NCT ID: NCT02041429 Org: User:
Start: 02/28/14 End: 01/31/21 Due: 01/31/22

Step Into Support for Endurance and Strength (SISTERS)

Phase: N/A Priority: Normal
NCT ID: NCT04354454 Org: User:
Start: 01/29/21 End: 03/17/23 Due: 03/17/24

Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00942682 Org: User:
Start: 07/31/09 End: 03/31/13 Due: 03/31/14

GVAX vs. Placebo for MDS/AML After Allo HSCT

Phase: N/A Priority: Normal
NCT ID: NCT01773395 Org: User:
Start: 01/08/13 End: 11/24/21 Due: 11/24/22

Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

Phase: N/A Priority: Normal
NCT ID: NCT03683680 Org: User:
Start: 10/31/18 End: 10/01/25 Due: 10/01/26

Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02036476 Org: User:
Start: 02/28/14 End: 07/31/16 Due: 07/31/17

Dilute Bleach Compresses for Radiation Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT04851522 Org: User:
Start: 06/09/21 End: 04/01/23 Due: 04/01/24

Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly

Phase: N/A Priority: Normal
NCT ID: NCT03609177 Org: User:
Start: 09/18/18 End: 09/30/24 Due: 09/30/25

Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03422003 Org: User:
Start: 04/01/18 End: 04/01/30 Due: 04/01/31